BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30678964)

  • 1. The adjuvant effect of C
    Liu J; Feng X; Chen Z; Yang X; Shen Z; Guo M; Deng F; Liu Y; Zhang H; Chen C
    Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():753-759. PubMed ID: 30678964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adjuvant effect of dispersed fullerene C60 on the immune response to constructs harboring amino acid and nucleotide sequences of hepatitis C virus nonstructural NS5B protein].
    Masalova OV; Lesnova EI; Andreev SM; Shershakova NN; Kozlov VV; Permyakova KY; Demidova NA; Valuev-Elliston VT; Turetskiy EA; Ivanov AV; Nikolaeva TN; Khaitov MR; Pronin AV; Kushch AA
    Vopr Virusol; 2023 Feb; 67(6):516-526. PubMed ID: 37264841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A candidate DNA vaccine elicits HCV specific humoral and cellular immune responses.
    Zhu LX; Liu J; Ye Y; Xie YH; Kong YY; Li GD; Wang Y
    World J Gastroenterol; 2004 Sep; 10(17):2488-92. PubMed ID: 15300890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant adenoviral vector expressing HCV NS4 induces protective immune responses in a mouse model of Vaccinia-HCV virus infection: a dose and route conundrum.
    Singh S; Vedi S; Li W; Samrat SK; Kumar R; Agrawal B
    Vaccine; 2014 May; 32(23):2712-21. PubMed ID: 24631092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines.
    Singh S; Vedi S; Samrat SK; Li W; Kumar R; Agrawal B
    PLoS One; 2016; 11(1):e0146404. PubMed ID: 26751211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adjuvant effect of polymuramil, a NOD1 and NOD2 agonist, differs when immunizing mice of different inbred lines with nonstructural hepatitis C virus (Flaviviridae:
    Lesnova EI; Masalova OV; Permyakova KY; Demidova NA; Valuev-Elliston VT; Ivanov AV; Kushch AA
    Vopr Virusol; 2023 Sep; 68(4):315-326. PubMed ID: 38156588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of hepatitis C vaccines.
    Garcia A; Fernandez S; Toro F; De Sanctis JB
    Recent Pat Inflamm Allergy Drug Discov; 2014; 8(2):85-91. PubMed ID: 25000932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy.
    Kumar A; Das S; Mullick R; Lahiri P; Tatineni R; Goswami D; Bhat P; Torresi J; Gowans EJ; Karande AA; Das S
    Vaccine; 2016 Feb; 34(8):1115-25. PubMed ID: 26700891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative analysis of the immune response to DNA constructions encoding hepatitis C virus nonstructural proteins].
    Masalova OV; Lesnova EI; Ivanov AV; Pichugin AV; Permiakova KIu; Smirnova OA; Tynitskaia VL; Ulanova TI; Burkov AN; Kochetkov SN; Ataullakhanov RI; Kushch AA
    Vopr Virusol; 2013; 58(2):21-8. PubMed ID: 23785766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A non-human hepadnaviral adjuvant for hepatitis C virus-based genetic vaccines.
    Levander S; Sällberg M; Ahlén G; Frelin L
    Vaccine; 2016 May; 34(25):2821-33. PubMed ID: 27109565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG immuno-stimulatory motifs enhance humoral immune responses against hepatitis C virus core protein after DNA-based immunization.
    Encke J; zu Putlitz J; Stremmel W; Wands JR
    Arch Virol; 2003 Mar; 148(3):435-48. PubMed ID: 12607097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of humoral immunity in mice by coupling pUCpGs10 and aluminium to the HCV recombinant immunogen.
    Zhan N; Xiu BS; Wang GH; Chen K; Bai GZ; Song XG; Zhu CX; Dai ZH; Yang XQ; Zhang HQ
    Virol J; 2011 Nov; 8():507. PubMed ID: 22054420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The combined application of nucleotide and amino acid sequences of NS3 hepatitis C virus protein, DNA encoding granulocyte macrophage colony-stimulating factor and inhibitor of regulatory T cells induces effective immune response against hepatitis C virus].
    Masalova OV; Lesnova EI; Shingarova LN; Tunitskaia VL; Ulanova TI; Burkov AN; Kushch AA
    Mol Biol (Mosk); 2012; 46(3):525-34. PubMed ID: 22888642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice.
    Cao J; Chen Z; Ren Y; Luo Y; Cao M; Lu W; Zhao P; Qi Z
    Vaccine; 2011 May; 29(20):3714-23. PubMed ID: 21396407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.
    Gummow J; Li Y; Yu W; Garrod T; Wijesundara D; Brennan AJ; Mullick R; Voskoboinik I; Grubor-Bauk B; Gowans EJ
    J Virol; 2015 Aug; 89(15):7991-8002. PubMed ID: 26018154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates.
    Jeong SH; Qiao M; Nascimbeni M; Hu Z; Rehermann B; Murthy K; Liang TJ
    J Virol; 2004 Jul; 78(13):6995-7003. PubMed ID: 15194776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
    Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of humoral and cellular immune responses by monophosphoryl lipid A (MPLA) as an adjuvant to the rabies vaccine in BALB/c mice.
    Hu X; Liu R; Zhu N
    Immunobiology; 2013 Dec; 218(12):1524-8. PubMed ID: 23816301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus precore protein augments genetic immunizations of the truncated hepatitis C virus core in BALB/c mice.
    Liao G; Wang Y; Chang J; Bian T; Tan W; Sun M; Li W; Yang H; Chen J; Zhang X; Bi S; Omata M; Jiang S
    Hepatology; 2008 Jan; 47(1):25-34. PubMed ID: 18074356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette-Guerin expressing multi-epitope antigen.
    Wei SH; Yin W; An QX; Lei YF; Hu XB; Yang J; Lu X; Zhang H; Xu ZK
    Arch Virol; 2008; 153(6):1021-9. PubMed ID: 18421415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.